Provider review, September 2026
MedSol Rx publishes a plan ladder whose totals multiply out correctly at every rung, and it runs a month-to-month lane beside the prepaid ones rather than only the cheapest. Its own product pages then tell readers the same medicine typically costs a range whose floor sits above the dearest rung it charges.
MedSol Rx also sells 2 compounds this site boards without publishing a price for them: NAD+ and Sermorelin.
MedSol Rx is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Every plan card states a per-month figure and a total, and each total multiplies out exactly against the months it covers.
That sounds like a low bar. It is not: a ladder whose totals do not reconcile is the most common defect on sellers that publish one.
It also publishes a month-to-month lane, with a first month and a standing rate after it, so a reader can see the cost of not committing.
The injectable semaglutide page names a typical monthly range for the programme whose floor sits above the top rung of the ladder the site actually sells.
The tirzepatide page does the same thing more sharply, naming a typical range whose floor is above every rung it charges and whose ceiling is several times higher.
Both figures are the seller's own. They are recorded here as they stand and neither is smoothed against the other.
Its NAD+ and its sermorelin each carry an indicative range that closes with "Please reach out to our team to request a personalized quote."
Neither is filed as a price here. A range with a quote-on-request attached is a lead capture, not a published figure.
Its plan cards carry a separate copy fault: the oral semaglutide card lists its own contents as a tirzepatide injection supply.
The company that makes the prescribing decision is named, which lets a reader look up the clinicians rather than only the storefront.
The dispensing pharmacy is not named anywhere on the pages read, and laboratory work is not part of what the fee buys.
On the regulatory question it is direct: compounded GLP-1 medications "are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality." Its coverage answer is thinner — it says it serves patients nationwide, with no count and no list.
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Read the full Trellis Vitality review
Trellis Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Trellis VitalityEvery one of them multiplies out correctly against the per-month figure printed beside it. That was checked rung by rung.
Its product pages carry typical-cost ranges whose floors sit above the top of its own ladder. Both sets of figures are the seller's, and the site does not reconcile them.
There is no published price. Both carry an indicative range that ends with a request to contact the team for a personalised quote, so neither is filed.
It does not say. The clinician network is named; the dispensing pharmacy is not.
MedSol Rx is not a paid partner; this link may earn a commission if that changes. Full disclosure.